Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update

Go back to Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update

Catyalyst Pharma (CPRX) Tops Q3 EPS by 1c

November 8, 2017 4:42 PM EST

Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

... More